Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 22.4.2006 | EN | Official Journal of the European Union | C 95/8 |

---

Prior notification of a concentration

(Case COMP/M.4198 — Bayer/Schering)

(2006/C 95/07)

(Text with EEA relevance)

|  |  |
| --- | --- |
| 1. | On 12 April 2006, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004[(1)](#ntr1-C_2006095EN.01000801-E0001) by which the undertaking Bayer Aktiengesellschaft (‘Bayer’, Germany) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the undertaking Schering Aktiengesellschaft (‘Schering’, Germany) by way of public bid announced on 23 March 2006 exercised by Dritte BV GmbH, a wholly owned subsidiary of Bayer. |

|  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- |
| 2. | The business activities of the undertakings concerned are:   |  |  | | --- | --- | | — | for undertaking Bayer: an international diversified group with activities in pharmaceuticals; |  |  |  | | --- | --- | | — | for undertaking Schering: a global research-based pharmaceutical company. | |

|  |  |
| --- | --- |
| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. |

|  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- |
| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (No (32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.4198 — Bayer/Schering, to the following address:   |  | | --- | | European Commission | | Competition DG | | Merger Registry | | J-70 | | B-1049 Brussels | |

---

[Top](#document1)